Ventripoint Diagnostics Income Statement

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	0.18	0.1	0.05	0.07	-
Revenue Growth (YoY)	89.06%	93.51%	-27.85%	-	-
Cost of Revenue	-	-	0.01	0.01	-
Gross Profit	0.18	0.1	0.04	0.06	-
Selling, General & Admin	3.21	3.93	3.89	3.92	3.25
Research & Development	0.37	0.97	1.08	1.05	0.46
Other Operating Expenses	-	-	-	-	0.01
Total Operating Expenses	3.58	4.9	4.97	4.97	3.72
Operating Income	-3.4	-4.8	-4.93	-4.91	-3.72
Interest Income	0.52	0.18	-0.01	0.01	-0.03
Other Non-Operating Income (Expense)	0.69	0.01	0.06	0.11	-0.2
Total Non-Operating Income (Expense)	1.21	0.19	0.05	0.12	-0.23
Pretax Income	-2.19	-4.62	-4.88	-4.79	-3.94
Provision for Income Taxes	-0.05	-0.08	-	-	-
Net Income	-3.2	-4.92	-4.87	-4.87	-3.88
Net Income to Common	-3.2	-4.92	-4.87	-4.87	-3.88
Shares Outstanding (Basic)	165	158	157	156	136
Shares Outstanding (Diluted)	165	158	157	156	136
Shares Change (YoY)	4.51%	0.93%	0.53%	14.62%	82.64%
EPS (Basic)	-0.02	-0.03	-0.03	-0.03	-0.03
EPS (Diluted)	-0.02	-0.03	-0.03	-0.03	-0.03
Shares Outstanding	165.41	157.48	156.82	156.82	155.56
Free Cash Flow	-1.55	-3.39	-3.8	-4.14	-3.15
Free Cash Flow Per Share	-0.01	-0.02	-0.02	-0.03	-0.02
Gross Margin	100.00%	100.00%	86.28%	84.80%	-
Operating Margin	-1889.37%	-5045.41%	-10024.80%	-7203.96%	-
Profit Margin	-1778.62%	-5169.14%	-9905.73%	-7148.33%	-
FCF Margin	-864.19%	-3557.98%	-7734.16%	-6068.54%	-
EBITDA	-3.34	-4.74	-4.86	-4.86	-3.67
EBITDA Margin	-1855.33%	-4979.35%	-9889.25%	-7129.29%	-
EBIT	-3.4	-4.8	-4.93	-4.91	-3.72
EBIT Margin	-1889.37%	-5045.41%	-10024.80%	-7203.96%	-
Effective Tax Rate	2.38%	1.81%	0.00%	0.00%	0.00%

Updated May 1, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.